Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Gu W, Geng J, Zhao H, Li X, Song G

Published in International Journal of Clinical Practice

Key Findings

Resveratrol modestly reduced fasting glucose, HbA1c and insulin resistance indices in people with type 2 diabetes.

Small glycemic benefit in diabetes with low-certainty evidence.

Small trials with substantial heterogeneity.

Compound

Resveratrol modestly reduced fasting glucose, HbA1c and insulin resistance indices in type 2 diabetes.

Primary

Resveratrol modestly reduced fasting glucose and HbA1c in type 2 diabetes.

Year:2022

Quality Score:6/10

This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.